Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06565117
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-18
Brief Title:
Efficacy of Dipotassium Glycyrrhizinate Emollients in the Maintenance Treatment of Adult Atopic Dermatitis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of Dipotassium Glycyrrhizinate Emollients in the Maintenance Treatment of Adult Atopic Dermatitis A Single-Center Randomized Controlled Study
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate whether emollients containing dipotassium glycyrrhizinate have a sustained improvement in the clinical severity of mild to moderate atopic dermatitis in adult
Detailed Description:
Atopic dermatitis atopic eczema AD is a common skin inflammatory disease dry skin and itchy skin is a significant symptom of most AD often accompany patients for life seriously affecting the physical and mental health and work life of patients The number of AD patients is increasing worldwide while the prevalence rate in China has increased more significantly in the past 10 years It is characterized by persistent skin dryness and a reduced function of the skin as a barrier to the external environment Encourage the free use of moisturizers emollients as a baseline treatment for AD and add anti-inflammatory therapy as needed Currently topical corticosteroids are still the first-line treatment options However studies have confirmed that patients with AD are cautious about the use of topical corticosteroids Maintaining the humidity of the skin and restoring the barrier function of the skin is the basis of the treatment of atopic dermatitis And studies have shown that regular use of emollients can improve skin hydration restore the skin barrier reduce the frequency of attacks and reduce the use of topical corticosteroids In patients with AD daily use of moisturizing emollients enhances the response to topical corticosteroid therapy reduce percutaneous water loss TEWL restore the skin barrier and promote hydration and can prevent or reduce AD attacks by improving the associated skin barrier defects prolonging the time between AD episodes The purpose of this study is to see whether emollients have sustained improvement on the clinical severity of adult atopic dermatitis in maintenance phase
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None